A Phase II Investigator Initiated Study of Acalabrutinib, Lenalidomide and Rituximab (aR2) in Patients with Previously Untreated High Tumor Burden Follicular Lymphoma

Saved in:
Bibliographic Details
Published in:Hematological oncology 2023-06, Vol.41 (S2), p.383-383
Main Authors: Strati, P., Feng, L., Westin, J., Nair, R., Gouni, S., Fayad, L., Rodriguez, M., Chihara, D., Malpica, L., Steiner, R., Gallardo, M., Nastoupil, L., Neelapu, S.
Format: Article
Language:English
Subjects:
Lymphoma
Rituximab
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.3164_277